TERBINAFINE HYDROCHLORIDE
- Product NDC
- 68071-2381
- 11-digit product format
- 680712381
- Labeler code
- 68071
- Product ID
- 68071-2381_4c11f8f8-404a-6320-e063-6394a90a12e5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terbinafine Tablets 250 mg
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA077137
- Marketing category
- ANDA
- Marketing start
- 2021-01-08
- Substance
- TERBINAFINE HYDROCHLORIDE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Allylamine Antifungal [EPC], Allylamine [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- TERBINAFINE HYDROCHLORIDE
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TERBINAFINE HYDROCHLORIDE | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 012C11ZU6G |
| Rxcui | 313222 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-2381-3 | TERBINAFINE HYDROCHLORIDE | 30 in 1 BOTTLE | TABLET | 30 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-2381 | TERBINAFINE HYDROCHLORIDE (TERBINAFINE TABLETS 250 MG) TABLET [NUCARE PHARMACEUTICALS,INC.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20210403_bf020c17-578f-74c4-e053-2995a90a9e7d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-2381-3 | 68071238103 | 30 TABLET in 1 BOTTLE (68071-2381-3) | 30 tablet | 2021-04-02 | 0000-00-00 | No | No | Current |